SG10201403557QA - Swine influenza hemagglutinin variants - Google Patents
Swine influenza hemagglutinin variantsInfo
- Publication number
- SG10201403557QA SG10201403557QA SG10201403557QA SG10201403557QA SG10201403557QA SG 10201403557Q A SG10201403557Q A SG 10201403557QA SG 10201403557Q A SG10201403557Q A SG 10201403557QA SG 10201403557Q A SG10201403557Q A SG 10201403557QA SG 10201403557Q A SG10201403557Q A SG 10201403557QA
- Authority
- SG
- Singapore
- Prior art keywords
- influenza hemagglutinin
- swine influenza
- variants
- hemagglutinin variants
- swine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16151—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16171—Demonstrated in vivo effect
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22042609P | 2009-06-25 | 2009-06-25 | |
| US22798609P | 2009-07-23 | 2009-07-23 | |
| US23402109P | 2009-08-14 | 2009-08-14 | |
| US25889009P | 2009-11-06 | 2009-11-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201403557QA true SG10201403557QA (en) | 2014-10-30 |
Family
ID=43386887
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2011085669A SG176178A1 (en) | 2009-06-25 | 2010-06-24 | Swine influenza hemagglutinin variants |
| SG10201403557QA SG10201403557QA (en) | 2009-06-25 | 2010-06-24 | Swine influenza hemagglutinin variants |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2011085669A SG176178A1 (en) | 2009-06-25 | 2010-06-24 | Swine influenza hemagglutinin variants |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US8088393B2 (en) |
| EP (1) | EP2448598B1 (en) |
| JP (1) | JP5745511B2 (en) |
| KR (1) | KR20120101318A (en) |
| CN (1) | CN102802666B (en) |
| AU (2) | AU2010266078B2 (en) |
| BR (1) | BRPI1014844A2 (en) |
| CA (1) | CA2766377A1 (en) |
| MX (1) | MX2012000123A (en) |
| NZ (2) | NZ596823A (en) |
| RU (1) | RU2560420C2 (en) |
| SG (2) | SG176178A1 (en) |
| WO (1) | WO2010151673A1 (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2448598B1 (en) | 2009-06-25 | 2016-03-30 | MedImmune, LLC | Swine influenza hemagglutinin variants |
| WO2013130132A1 (en) * | 2011-10-07 | 2013-09-06 | Medimmune, Llc | Influenza hemagglutinin variants |
| KR101315273B1 (en) * | 2012-10-29 | 2013-10-08 | 대한민국 | Strengthened mutant strain of influenza virus |
| WO2014086732A2 (en) | 2012-12-03 | 2014-06-12 | Novartis Ag | Influenza virus reassortment |
| MA44179B1 (en) * | 2014-05-13 | 2020-10-28 | Univ Pennsylvania | Compositions comprising an adeno-associated virus expressing double antibody constructs and their uses |
| US9616114B1 (en) | 2014-09-18 | 2017-04-11 | David Gordon Bermudes | Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity |
| CN108135994B (en) | 2015-05-13 | 2022-01-25 | 宾夕法尼亚州大学信托人 | AAV-mediated expression of anti-influenza antibodies and methods of use thereof |
| US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
| US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| JOP20190200A1 (en) | 2017-02-28 | 2019-08-27 | Univ Pennsylvania | Compositions useful in treatment of spinal muscular atrophy |
| FI3589730T3 (en) | 2017-02-28 | 2024-02-22 | Univ Pennsylvania | Adeno-associated virus (aav) clade f vector and uses therefor |
| TW201837170A (en) | 2017-02-28 | 2018-10-16 | 賓州大學委員會 | Novel AAV mediated influenza vaccines |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5382425A (en) * | 1992-01-13 | 1995-01-17 | Syntro Corporation | Recombinant swinepox virus |
| US7871626B2 (en) * | 2005-08-04 | 2011-01-18 | St. Jude Children's Research Hospital | Modified influenza virus for monitoring and improving vaccine efficiency |
| CA2626266C (en) * | 2005-10-17 | 2015-09-08 | Medimmune, Llc | Multi plasmid system for the production of influenza virus |
| JP2010500034A (en) * | 2006-08-09 | 2010-01-07 | メッドイミューン バクシーンズ，インコーポレイティド | Influenza hemagglutinin mutant and neuraminidase mutant |
| US20080299151A1 (en) * | 2007-05-31 | 2008-12-04 | Statens Serum Institut | Influenza vaccines |
| EP2448598B1 (en) | 2009-06-25 | 2016-03-30 | MedImmune, LLC | Swine influenza hemagglutinin variants |
-
2010
- 2010-06-24 EP EP10792667.7A patent/EP2448598B1/en not_active Not-in-force
- 2010-06-24 RU RU2012102385/10A patent/RU2560420C2/en not_active IP Right Cessation
- 2010-06-24 MX MX2012000123A patent/MX2012000123A/en not_active Application Discontinuation
- 2010-06-24 SG SG2011085669A patent/SG176178A1/en unknown
- 2010-06-24 WO PCT/US2010/039826 patent/WO2010151673A1/en active Application Filing
- 2010-06-24 CA CA2766377A patent/CA2766377A1/en not_active Abandoned
- 2010-06-24 KR KR1020127000803A patent/KR20120101318A/en not_active Application Discontinuation
- 2010-06-24 NZ NZ596823A patent/NZ596823A/en not_active IP Right Cessation
- 2010-06-24 SG SG10201403557QA patent/SG10201403557QA/en unknown
- 2010-06-24 AU AU2010266078A patent/AU2010266078B2/en not_active Ceased
- 2010-06-24 BR BRPI1014844A patent/BRPI1014844A2/en not_active IP Right Cessation
- 2010-06-24 JP JP2012517731A patent/JP5745511B2/en not_active Expired - Fee Related
- 2010-06-24 CN CN201080027726.4A patent/CN102802666B/en not_active Expired - Fee Related
- 2010-06-24 NZ NZ617191A patent/NZ617191A/en not_active IP Right Cessation
- 2010-06-24 US US12/822,781 patent/US8088393B2/en not_active Expired - Fee Related
-
2011
- 2011-12-01 US US13/308,809 patent/US8715691B2/en not_active Expired - Fee Related
-
2014
- 2014-06-25 AU AU2014203458A patent/AU2014203458A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| RU2012102385A (en) | 2013-07-27 |
| EP2448598A1 (en) | 2012-05-09 |
| AU2010266078A1 (en) | 2011-12-22 |
| MX2012000123A (en) | 2012-03-07 |
| KR20120101318A (en) | 2012-09-13 |
| CN102802666A (en) | 2012-11-28 |
| NZ617191A (en) | 2015-06-26 |
| US8088393B2 (en) | 2012-01-03 |
| WO2010151673A1 (en) | 2010-12-29 |
| CA2766377A1 (en) | 2010-12-29 |
| US8715691B2 (en) | 2014-05-06 |
| EP2448598A4 (en) | 2013-10-23 |
| AU2014203458A1 (en) | 2014-07-17 |
| US20110123559A1 (en) | 2011-05-26 |
| CN102802666B (en) | 2015-06-03 |
| JP5745511B2 (en) | 2015-07-08 |
| AU2010266078B2 (en) | 2014-08-14 |
| SG176178A1 (en) | 2011-12-29 |
| NZ596823A (en) | 2013-11-29 |
| JP2012531205A (en) | 2012-12-10 |
| US20120244600A1 (en) | 2012-09-27 |
| EP2448598B1 (en) | 2016-03-30 |
| RU2560420C2 (en) | 2015-08-20 |
| BRPI1014844A2 (en) | 2019-09-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG10201403557QA (en) | Swine influenza hemagglutinin variants | |
| GB0810305D0 (en) | Influenza vaccination | |
| EP2318043A4 (en) | Influenza hemagglutinin and neuraminidase variants | |
| HK1143085A1 (en) | Low-additive influenza vaccines | |
| HK1200845A1 (en) | Influenza hemagglutinin variants | |
| PL2358386T3 (en) | Optimized influenza vaccines | |
| GB0919333D0 (en) | Sterilising emitter | |
| ZA201300395B (en) | Influenza vaccine | |
| PL2396032T3 (en) | Influenza vaccines with reduced amounts of squalene | |
| GB201006165D0 (en) | Vaccine | |
| GB0918679D0 (en) | Influenza vaccine | |
| ZA201100962B (en) | Influenza vaccines | |
| EP2486054A4 (en) | Recombinant antibodies against h1n1 influenza | |
| SG11201503229SA (en) | Swine influenza hemagglutinin and neuraminidase variants | |
| EP2291545A4 (en) | Influenza sequences | |
| SG2014010185A (en) | Influenza hemagglutinin and neuraminidase variants | |
| EP2368899A4 (en) | Avian influenza vaccine | |
| SI2482845T1 (en) | Novel vaccine composition against influenza | |
| GB201000522D0 (en) | Vaccine | |
| HK1243353A1 (en) | Canine influenza vaccines | |
| EP2424879A4 (en) | Influenza vaccine | |
| FI8653U1 (en) | Nozzle | |
| HK1177692A1 (en) | Novel influenza virus | |
| EP2240199A4 (en) | Influenza b vaccines | |
| FI20095951A0 (en) | spray |